Article Information
History
- June 20, 2017.
Article Versions
- Version 1 (October 24, 2016 - 14:50).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Enrique Carrillo-de-Santa-Pau16,
- David Juan1,26,
- Vera Pancaldi1,3,
- Felipe Were1,
- Ignacio Martin-Subero4,
- Daniel Rico5,7,
- Alfonso Valencia1,3,7,
- on behalf of The BLUEPRINT Consortium8
- 1Structural Biology and BioComputing Programme, Spanish National Cancer Research Centre (CNIO)
- 2Institut de Biologia Evolutiva, Consejo Superior de Investigaciones Científicas–Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, Barcelona, Catalonia 08003, Spain
- 3Barcelona Supercomputing Centre (BSC), Barcelona, Spain.
- 4Institut d’Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Department of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, Barcelona, Spain.
- 5Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
- 8Member of International Human Epigenome Consortium (IHEC). For more information, see http://www.blueprint-epigenome.eu and http://ihec-epigenomes.org
- ↵7 Co-senior and corresponding authors daniel.rico{at}newcastle.ac.uk, alfonso.valencia{at}bsc.es